Related by context. All words. (Click for frequent words.) 71 B.1 64 B.3 63 C.1 62 .W. McNichols 61 Explanatory Notes 61 #.#-# [005] 61 Annexures 61 Continuous Disclosure 60 .execute arbitrary SQL 60 #.# subd [004] 60 O. Reg 60 B.2 59 TABLE OF CONTENTS 59 Proposed Revisions 59 Recent Accounting Pronouncements 59 § #-# [004] 59 1.a. 59 Income Tax Regs 59 cmt 59 Supplementary Data 59 Temporary Suspension 59 DFARS #.#-# 58 Comparative Figures 58 IBTimes.com More 58 Appendix 4E 58 Content Outline 58 Original Bidder Statement 58 Disclosure Requirements 58 #.#-# b [001] 58 #.#-# Offeror Representations 58 See Restatement Second 58 Cautionary Factors 58 FAR #.#-# Offeror Representations 58 #d# [001] 58 Listing Requirements 58 Anders Bylund More 58 § #-#-# [002] 58 Regulations Governing 58 #.#.#.# [011] 58 Legal #.# 58 Colo. Sess 57 Reconciliation Tables 57 titled SUPPLEMENTAL DISCLOSURE 57 FAR #.#-# [001] 57 MANAGEMENT DISCUSSION AND ANALYSIS 57 doi doi 57 thereof Controls 57 § #.#-# [004] 57 Certifications Commercial 57 Okla. Stat 57 Antidumping Duties 57 § #:# [002] 57 :5 57 #-#.# [014] 57 Explanatory Note 57 Antidumping Duty Order 57 #A.# [005] 57 #CCD 57 -Genereaux 57 FINANCIAL SERVICES GUIDE 57 C.2 57 Offerors Commercial 57 Appendix B 57 #.#-# Instructions 57 De Minimis 57 annexed hereto 57 Rev. Proc 57 consequential amendments 57 CFR pt 56 AQUARIUS PLATINUM LIMITED 56 Appendix 5B 56 FAR #.#-# [003] 56 Eur Urol 56 Disclosure Controls 56 Regulatory Developments 56 Sean Yuille ¤ 56 Matters Relating 56 Compl 56 Classification Tonnes 56 #.#-# Contract Terms [002] 56 constitutes discloseable transaction 56 Def. s 56 Proxy Disclosure 56 NJSA 2C :5 56 #.#-# Convict Labor 56 Going Concern Qualification 56 #.#.#.#.#.# 56 quoting Restatement Second 56 Administrative Procedure 56 II Item 9A 56 #.#-# [020] 56 CFR #.# [005] 56 Opp'n 56 Pricing Supplement 56 subparagraphs 56 END FOOTNOTE 56 Segregated Facilities 56 Disclosure Requirement 56 Customs Tariff Act 56 #A #B [002] 56 Dan Dzombak More 56 #.#-# [013] 56 -0 Key 56 CEQA Guidelines 56 § #:# [001] 55 Miscellaneous Provisions 55 § § #-#-# [001] 55 #.#-# [016] 55 #.#.# [013] 55 #.#-# b [002] 55 Supplementary Appendix 55 #:#-# Abstract Free [009] 55 Multilateral Instrument 55 Follow @ JohnCFierce 55 Offerors Commercial Items 55 SYSC 55 Judgments § 55 Sec.# [002] 55 USC § #u 55 CORPORATE DIRECTORY 55 Travis Hoium More 55 CFR § #.# [002] 55 Certifications Commercial Items 55 Docket Entry No. 55 Stmt 55 TCA § #-#-# [003] 55 REGARDING NON GAAP 55 Section #C [001] 55 #a subdivision 55 § #a [002] 55 C.# 55 CFR #.# [002] 55 Severability 55 WpHG mit dem Ziel 55 2d ed 55 Repl. 55 CFR § #.# [006] 55 Regulation SX 55 Exh 55 Coalcorp Provides Updated 55 Id. § 55 CFR #.#b 55 CFR § #.# [004] 55 #.# 5T 55 Ordinance Cap. 55 Flexpoint Announces 55 SEC Regulation SX 55 CONTENTS Page 55 :9 55 #g# 2 55 Concession Arrangements 55 Dan Caplinger More 55 Immediate Effectiveness 55 Reporting Obligations 55 § #.#.# [001] 55 Obligatoires 54 Follow @ FierceBiotech 54 # et seq 54 #.#-# [001] 54 FAR #.#-# Instructions 54 See USSG 54 #.# subd [006] 54 § #.#.# [002] 54 INDUSTRY DEFINITION Industry 54 Capitalised terms 54 To Length Au 54 Conversion Factor 54 Arch Dermatol 54 Torts § 54 Chemical Substances 54 App'x 54 STATE STREET CORPORATION 54 Motor Vehicle Ordinance 54 1A Risk Factors 54 2.a. 54 Note Concerning Forward 54 Topics Covered Executive 54 #.#.#R 54 = document.location.protocol 54 Alloying 54 Listing Rule #.#A 54 ISIN Number 54 Offerors Commercial applies 54 § #-#.# [003] 54 Explanatory notes 54 RISKS AND UNCERTAINTIES 54 Appendix 4D 54 Statistical Tables 54 Sequential Quarterly 54 Maj. Op 54 § #-#.# [001] 54 Counterparty Criteria 54 theSecurities Act 54 CFR #.# c 54 Pl. 54 Reply Brief 54 Wheat Starch 54 #:#-# Abstract Free [008] 54 Anti Dumping Duties 54 Appendix 1A 54 Determining Whether 54 CFR § #.# [008] 54 CFR #.# d 54 § #.# [002] 54 Van Kampen Closed End 54 Accounting Practices 54 #.# RSMo 54 Pattern Jury 54 SEBI ICDR Regulations 54 .PokerStars EPT 54 § #-#-# [004] 54 Cautionary Information 54 #.# subdivision [004] 54 Offeror Representations 54 Interval m 54 FAR #.#-# Evaluation 54 See USSG § #B#.# 54 Periodic Reports 54 #:#-# [014] 54 Consequential Amendments 54 Fraudulent Transfer 54 subsequent amendments thereto 54 OCGA § #-#-# [002] 54 Supplementary Explanatory Memorandum 54 TCA § 54 #:#-# Abstract Free [007] 54 #:#-# Abstract Free [001] 54 Conforms 54 Matt Koppenheffer More 54 dated #.#.# [002] 54 Article XVII 54 #/#/EEC [002] 54 Italian Legislative Decree 53 Constitutes 53 NJSA 2C :2 53 Legal Practitioners Act 53 Restated Declaration 53 BOFIA 53 Bulletin des Annonces 53 CFR § #.#b 53 Enumerated 53 COMPANY CONSOLIDATED INCOME STATEMENTS 53 Quantitative Ability 53 NJSA #A 53 Transitional Provisions 53 S/#/# 53 Regulation RRO 53 Pa.RAP 53 .cagy veteran 53 Red Hat alert RHSA 53 USC #d 53 RESOURCE ESTIMATE 53 FINAL REPORT 53 Filing Requirements 53 L.#/# 53 Supplementary Prospectus 53 Act Cap. 53 -0 Contents 53 HERE LIVE 53 Ordinary Dividends 53 #.#-# #.#-# #.#-# #.#-# 53 Appendix I. 53 Non GAAP reconciliations 53 Seth Jayson More 53 E.1 53 DEALINGS BY 53 Applicability 53 Verbal Ability 53 NJSA #:#-# [004] 53 Contained Contained 53 Supplementary Product 53 Segregated Facilities Feb 53 Eur J Cancer 53 Reply Br 53 Referenced 53 Brief Description 53 Equiv 53 Their Respective 53 Continued Listing Requirements 53 Width m 53 ITEPA 53 #:#-# Abstract Free [006] 53 pari materia 53 HRS § #-# [001] 53 Material Fact 53 Proven Mineral Reserves 53 Regulatory Announcement 53 + - [002] 53 § #-#-# [005] 53 #:#-# [037] 53 CFR § #.# [001] 53 Accounting Policies 53 #.#-# Evaluation Commercial 53 Contained Metal 53 Reevaluation 53 #:#-# Abstract Free [004] 53 Procurement Procedures 53 Employee Handbooks 53 Reconstitute 53 Undisputed Facts 53 annexure marked 53 Randomized Controlled Trials 53 Penal Code Cap 53 Preferred Stock Dividend 53 FAR #.#-# Equal Opportunity 53 #:#-# Abstract Free [005] 53 -Richard Gitlen 53 CUSIP ISIN 53 -Baralt 53 § #a [003] 53 END FOOTNOTE * 53 Va. Code § 53 SPECIAL BUSINESS 53 entitled Caution Regarding 53 Proposed Rule Changes 53 w xml 53 Corrupt Practices 53 -Wauk 53 Cash Flow Statements 53 #C #CCC 53 Pl. s 53 Brief Profile 53 By 3lilangels Read 53 #.#-# Prohibition 53 Chapter 6D 53 ADOPTION OF THE 53 subsection c 53 CRITICAL ACCOUNTING ESTIMATES 53 EXPLANATORY MEMORANDUM 53 Safeguard Measures 53 #-#-# [062] 53 Headwaters Incorporated Announces 53 Condensed Consolidated Interim 52 discloseable transaction 52 Stipulated 52 #:#-# [019] 52 RH DONNELLEY CORPORATION 52 Legal Notices 52 ANNEXURE 52 Logical Reasoning 52 SEC Rule #g# 52 6 pgs #k 52 THE WARNACO GROUP INC. 52 Corporate Governance Principles 52 Quarterly Dividends 52 #A.# [003] 52 Issuer Amended 52 #:#-# Abstract Free [003] 52 DOSAGE AND ADMINISTRATION 52 Minn. R. Evid 52 Corporate Governance Policies 52 NYSE Amex Listing 52 AFI #-# 52 INVESTMENTS LTD 52 ANNUAL REPORT 52 Arch Pediatr Adolesc Med 52 Am J Clin 52 Exs 52 Sec.# [001] 52 Section #-#-# [006] 52 Resp 52 Restated Promissory Note 52 Defs. 52 Amending Directive 52 #:# -# Abstract Free [001] 52 #:#-# Abstract Free [010] 52 CFR § #.# [003] 52 Fam. Code § 52 ABN AMRO Warrants 52 Mineral Resource Summary 52 Conditions Precedent 52 § #A.# 52 USC § #a [002] 52 ZAE # 52 Chp 52 ASX Listing 52 Gluten Powder 52 Components Thereof 52 Import Duty 52 BUFC Equity Securities 52 #/#/EEC [001] 52 #:#-#,# Abstract Free 52 Appendices 52 See id 52 #:#-# [002] 52 Criminal Procedural Code 52 #,#,#,# #,#,#,# #,#,#,# 52 Cost Reduction Strategy 52 -Rejustors 52 ACCOUNTING STANDARDS 52 PARAGRAPH 52 Antidumping Duty 52 Subsector 52 FAR #.# 52 doi Abstract Free 52 III.#.# 52 Joint Stipulation 52 Box Grading 52 Takeovers Regulations 52 Proposed Regulations 52 #.# subds [001] 52 FASB Emerging 52 -Horntvedt 52 Summary Table 52 Vertical Restraints 52 Reference Document 52 Sentencing Guidelines Manual 52 Files Amended 52 Position EITF #-#-# 52 CORPORATE GOVERNANCE STATEMENT 52 Tenn. R. Civ 52 Directors Shareholdings 52 Cash Flow Statement 52 Issues Relating 52 Smooth Muscle 52 Preferential Issues 52 Stapling Proposal 52 -# -# [006] 52 #:# -# [005] 52 FIRST DATA CORPORATION 52 Non Exempt 52 ACCOUNTING POLICIES 52 Prejudicial 52 § #.#-# et seq 52 RESTATEMENT SECOND OF 52 -Sen. Larcenia Bullard 52 CFR #.# [001] 52 Cashflow Report 52 Proposed Private Placement 52 #S #S [003] 52 5TH CIR 52 Compulsory Licensing 52 #-# #-# [013] 52 E/CN.#/#/# 52 Subparagraph 52 Restated Letter 52 Accounting Guideline 52 ASX Listing Rules 52 Cont. 52 § #.# [004] 52 #/#/# Appendix 3B [003] 52 IMPORTANT DATES 52 Continued Airworthiness 52 Attached hereto 52 -vs. Sonjay Dutt 52 #:#-# Abstract Free [002] 52 Ark. Sup 52 CREATE TABLE 52 non GAAP Measures 52 b Vernon Supp 52 Age Suitability 52 -0 Content Outline 52 Important Notices 52 Waste Discharge 52 Persons Discharging Managerial Responsibilities 52 Generally Accepted 52 Zcom Networks Announces 52 Contents Introduction 52 Add.1 52 Practice Direction 52 #-#.# [016] 52 Subtitle C 52 OCGA § #-#-#.# 52 Note Indenture 52 #CCC 52 #:# -# Abstract Free [002] 52 Pa.CS § 52 #,# #,# [003] 52 NASDAQ Deficiency Notice 52 DFARS 52 3d ed 52 Civil Procedure Rule 52 enclosed herewith 51 Guidance Document 51 NJSA #:#-#.# [003] 51 Osteoarthritis Pain 51 General Accepted Accounting 51 hereof shall 51 SHENGDATECH INC. AND SUBSIDIARIES 51 R.# [002] 51 Dangerous Substances 51 ASX Announcements 51 Fundamentally Flawed 51 #.#-# [033] 51 OKO Oyj 51 Compensation Disclosure 51 DTR #.#.# b 51 APPENDIX 4E 51 Short Explanation 51 Vernon Supp 51 Conversion Ratio 51 Hedging Relationships 51 Admissible 51 CICA Accounting Guideline 51 Filing Status 51 Funds Declare Dividends 51 Remote SQL Query 51 Concluding Observations 51 FAR Clause #.#-# 51 CONVERSION OF 51 transactions contemplated thereunder 51 #.# [042] 51 § #-#-#.# 51 #A.# [001] 51 Adverse Reactions 51 KRS #A.# [002] 51 EDGAR Online via COMTEX 51 ARS § 51 SIGNIFICANT ACCOUNTING POLICIES 51 KSA #-# [001] 51 SAFE HARBOUR 51 Eligibility Requirements 51 SEBI Guidelines 51 Option Grants 51 Non GAAP Measure 51 :4 51 AND CONTROLLED ENTITIES 51 EXPLANATORY STATEMENT 51 LSA RS #:# [002] 51 Terms Companies Mentioned 51 Dry Powder Inhalers 51 AFEP MEDEF 51 Implementing Regulations 51 KAR #:# 51 Section #.# [001] 51 Mandatory Arbitration 51 Acctg 51 Psychol 51 uncertificated registered 51 Condensed Cash Flow 51 Unaudited Reconciliations 51 ASC# 51 Procedural Requirements 51 SHIRE PLC 51 Reporting Requirements 51 http:/www.grassrootinstitute.org/ 51 Payment Structure 51 Critical Accounting Policies 51 HSW Act 51 Miscellaneous Receipts 51 -Amaka Anajemba 51 meanings ascribed 51 Supplementary Material 51 Indemnities 51 GASB Issues 51 GLOSSARY 51 Criminal Offence 51 Anworth Announces 51 KRS #.# [003] 51 Sodium Intake 51 Stent Placement 51 Ownership Structure 51 Section #-#-# [005] 51 D.2 51 See Attachment 51 Arms Export 51 PremierWest Bancorp Announces 51 See ARS § 51 Paragraphs 51 Authorisations 51 Ala. R. Civ 51 First BanCorp Announces 51 PUBLIC NOTICE 51 p.# [001] 51 NJAC #:#-#.# 51 USC § #f 51 INTRODUCTION I. 51 #.#c #.#c [006] 51 Dkt. # 51 Announces Effectiveness 51 Restatement Process 51 Prognostic Factors 51 Bloodborne Pathogens 51 Slip Op 51 Dkt 51 ICESCR 51 HKAS 51 annexure mark 51 #.#-# Equal Opportunity 51 Dried soup 51 Hr'g Tr 51 Material Facts 51 Related Transactions 51 #.#d [003] 51 #A #A [002] 51 CFR #.# b 51 WADA Prohibited List 51 NASDAQ Delisting 51 USC § #a [003] 51 Wyo. Stat 51 & pagename = 51 Explosive Substance Act 51 applies prospectively 51 #.#-# [003] 51 #B#.# 51 Pa.CSA § 51 Appendixes 51 GOV/#/# 51 Resource Estimation 51 Script Insertion Vulnerability 51 HTSUS 51 C.3 51 Antitrust Laws 51 Arbitration Agreements 51 recodified 51 FINANCIAL STATEMENTS 51 Item 9A 51 subparagraph B 51 WESTWOOD ONE INC. SUPPLEMENTAL 51 Critical Accounting 51 Second Supplementary Bidder 51 Ethical Considerations 51 § #-#.# [002] 51 CFR #.# [006] 51 A/#/# [002] 51 attached herewith 51 Resp't 51 Minn. R. Civ 51 RSMo 51 Declared Effective 51 #.#-# Contract Terms [001] 51 Majority Voting 51 Anti Avoidance 51 Beneficial Owner 51 R. #:#-# 51 section #-#-# [001] 51 No.#/# [003] 51 Dip Azimuth 51 Exclusionary 51 Legal Proceedings 51 Legal Entity 51 Dividend Payment 51 Accounting Auditing 50 Corporate Governance Statement 50 - -Crazyhorse 50 WITH PREJUDICE 50 Inland Revenue Ordinance 50 Suppl 50 Administrative Proceeding File 50 Pro Rata 50 ASC Topic #-# 50 #-#-#.# [002] 50 Defined Terms 50 var gaJsHost = https 50 B.5 50 Previously Disclosed 50 #ff [001] 50 Atmospheric Carbon Dioxide 50 Half Yearly Report 50 Tex. Admin 50 Code # 50 IEC #-#-# [003] 50 subclause 50 Cosmetic Ingredients 50 Annual Audited Consolidated 50 Premerger Notification 50 NAICS # [001] 50 www.x cal.com 50 Binding Offer 50 Continuous Disclosure Policy 50 Palladon Announces 50 Regular Monthly Distributions 50 w illus 50 Def. 50 CSR #-#.# 50 IV.#.# 50 NexgenRx Announces 50 Fetal Pain 50 punctuation omitted 50 BioFuel Announces 50 meaning ascribed thereto 50 Explanatory 50 Antitumor 50 APPLICATION OF 50 Stockholder Approval 50 La.RS #:# [003] 50 AS NZS #:# 50 CFR § #.# [007] 50 Rule #.#A 50 HEALTH SYSTEMS INC. AND 50 #.#.#.#.# [004] 50 SIFT Rules 50 NOT NULL 50 Adam Vogler 50 Articles Supplementary 50 SEBI Substantial Acquisition 50 Amount Amount 50 Jury Instructions 50 Subsidiary Arrangements 50 IAEA Statute 50 Annexes 50 Scrip Dividend Scheme 50 directive #/#/EC [002] 50 USC § #c 50 Act Pub. L. 50 #a [004] 50 -John F. Biemeck 50 2nd edn 50 STATUTORY 50 Preliminary Findings 50 CFR § § #.# [001] 50 Promulgated 50 -Epidemiol 50 Non GAAP Measurements 50 Ore Reserves JORC Code 50 Reproduced Record RR 50 SEBI Delisting 50 Saprolite mafic intrusive 50 Qtr Ended 50 #b c 50 Balance Sheet Cash Flow 50 #S #S [001] 50 Restatements 50 Tabular 50 Looking Statements Safe Harbor 50 #.#A [006] 50 p.2 50 IFRS IFRS 50 Domicile Australia 50 No. #R Consolidation 50 #-#-# [070] 50 Listing Rule #.#.# [003] 50 Election Symbols Reservation 50 Subsections 50 Directive #/#/EC [006] 50 Plaintiffs Complaint 50 Substantial Shareholding 50 USC § #a [001] 50 Risks Regarding Forward 50 DEFINITIONS 50 Technical Specifications 50 Westpac TPS 50 CICA issued 50 C.4 50 #.# [023] 50 Article XIV 50 Competent Persons 50 NOTIFICATION OF MAJOR INTERESTS 50 § #-#-# b [003] 50 vphl Norwegian Securities 50 Differential Diagnosis 50 Accounting Guideline AcG 50 Miscellaneous Amendments 50 #-#.# [017] 50 Stimmrechtsmitteilung pursuant 50 Systemically Important 50 APPENDIX 3B 50 b Disclosure SmallcapInsights.com 50 § #B#.# [002] 50 Provides Detailed 50 Mineral Resource Estimation 50 Fully Compliant 50 II.#.# 50 Clause #.#.# 50 Topics Covered 50 Different Types 50 CFR #.# [008] 50 Nasdaq Deficiency Notice 50 preambular 50 CFR § § 50 Proposed Reorganization 50 Grantor Trust 50 Psychotropic Drugs 50 Ark. R. Civ 50 Appendix 50 Naturally Occurring 50 Qualified Deferred Compensation 50 Simplified Acquisition 50 Healthful Eating 50 La.Code Crim.P. art 50 § 8C 50 Dividend Payout 50 Crowflight Announces 50 Bilgena Read Terms 50 Obviousness 50 ALASKA COMMUNICATIONS SYSTEMS GROUP 50 Statutory Accounting Principles 50 Intellectual Property Infringement 50 Fiduciary Duties 50 Docket Entry 50 Wisconsin Statutes 50 NUREG 50 Harmonized Commodity 50 SPECTRUM BRANDS 50 Interrogation Techniques 50 Healthnostics Announces 50 § #A [001] 50 USSG § #B#.# [002] 50 Releases Audited 50 Pls. 50 NJSA #:#-# [001] 50 Statutory Audit 50 KEMET Announces 50 Ord. 50 MCL #.# [002] 50 NJAC 6A 50 Enforceability 50 May Affect ViewSonic 50 Administrative Proceeding 50 Directors Persons Discharging 50 Kaydon Corporation Announces 50 Mineral Reserves Best Practices 50 Mandatory Conversion 50 Plea Bargaining 50 Foreign Currency Translation 50 Protherics PLC announces 50 FINANCIAL RISK MANAGEMENT 50 Issues Notice Regarding 50 Shelf Registration Statement 50 CA BUSINESS 50 accompanying Entitlement 50 Ozone Pollution 50 CFR § § #.# [002] 50 Procedure Rules 50 Article XVIII 50 EPA Proposes 50 Cautionary Notes 50 NJSA #:#-# [002] 50 GENERAL ELECTRIC COMPANY 50 Stripping Costs Incurred 50 2C :# 50 AUDITED 50 Subsoil 50 Medicure Announces 50 Ineffective Assistance 50 Tst 50 Paavo Moilanen Senior 50 Contingent Commissions 50 FR Doc 50 Previously Issued 50 Offer Document dated 50 Wireless Legal Footnote 50 Derivative Contracts 50 MRTP Act 50 OF CIRCULAR 50 Beneficial Ownership 50 Items affecting comparability 50 NJSA #A :# 50 :# [002] 50 Tenn. R. Evid 50 LSA CCP art 50 #:# [013] 50 Combustible Dust 50 Over Subscribed 50 CALJIC 49 SEDAR Filings 49 Double Taxation Agreements 49 Looking Statements Except 49 Delimitation Act 49 Clarifies Status 49 FERC Stats 49 Special UpstageMagazine.com Online 49 Appendix 3B Page 49 op cit 49 A/#/# [001] 49 MCL #.# [001] 49 CRD3 49 Appendix 4E Preliminary 49 Segmental 49 DC Code § 49 GRIH Web site 49 NRS #.# [003] 49 Occupational Pension Schemes 49 OCGA § #-#-# [006] 49 Endnotes 49 Verbal Reasoning 49 Acquisition constitutes discloseable 49 ORS #A.# 49 Dkt. 49 Syllabi 49 REACH Regulation 49 First Supplementary Bidder 49 Pending Litigation 49 R.# [001] 49 Restatement Third 49 Section #b 49 Liability Lawsuits 49 Pg. 49 SAMREC 49 rev. ed 49 Capital Disclosures 49 Concerning Forward Looking Statements 49 Dividends Paid 49 Factors Impacting 49 MR Civ 49 constitute discloseable transaction 49 #.#.# [023] 49 See Deepcaster 49 Substantial Shareholder Interest 49 WILL PROVE TO BE 49 CONTENTS 49 READER ADVISORY 49 Risks Associated 49 Ariz. Sess 49 Rev. Rul 49 § § #-# [003] 49 contravenes Article 49 #/#/# Director PDMR 49 #.# subd [003] 49 Unsecured Claims 49 Aplt 49 Statutory Accounts 49 ErP 49 Article VIII 49 Corporations Act ASX Listing 49 Criminal Offences 49 Analytical Methods 49 Supplemental Data 49 Comparability 49 Replacement Prospectus 49 Criminal Procedure Law 49 Docket ID 49 Proposed Changes 49 Mineral Resource estimation 49 ANNUAL FINANCIAL REPORT 49 BIOLASE Announces 49 Contracts § 49 Constitutive Act 49 Asylum Procedures 49 satan# 49 Remote SQL Injection 49 [004] 49 Mad Cow Testing 49 Risks Related 49 Evid 49 wef #.#.# [001] 49 Règlement 49 section #-#-# [003] 49 Director Shareholding 49 SEBI Disclosure 49 Ethical Reasoning 49 RECONTRUST COMPANY NA 49 ORS #B.# 49 Dosage Forms 49 Regulatory Regime 49 Imports Exports 49 Supplemental Schedule 49 Stock Option Expensing 49 ADJUDGED 49 CAS #-#-# Market [001] 49 Non Recurring 49 Alexco Announces 49 MSc Qualified Person 49 Drill Hole Location 49 FINANCIAL REPORT 49 Eminent Domain Procedure 49 TO HOLDERS OF 49 HERALD #/#/# 49 #-#-# [053] 49 Resale Registration Statement 49 NanoMarkets Releases 49 pgs #k 49 DFAR #.#-# 49 Financing Arrangements 49 Statutory Basis 49 Eur Heart 49 Subsection b 49 Width Grade 49 Reviewed Reviewed 49 USC #a [002] 49 Alleged Violations 49 #.# subdivision [001] 49 Postal Privatization 49 Listing Application 49 Private Securities LitigationReform Act 49 LSA RS #:# [001] 49 FCC Rcd 49 Graphics Legal Footnote 49 Inc. Discloses Sources 49 IRC § § 49 UNAUDITED CONDENSED CONSOLIDATED SUMMARY 49 Inadmissible 49 Clinical Practice Guideline 49 section #AA 49 INDUSTRY STRUCTURE 49 Connected Transactions 49 BEE Transaction 49 Section #A.# 49 EXPECTED RESULTS MAY INCLUDE 49 FAR #.#-# Prohibition 49 Third Amended Complaint 49 Personnel Policies 49 Adverse Effect 49 Reference Materials 49 Warrant Indenture 49 Cautionary Announcement 49 Complementarity 49 What Constitutes 49 Commission Decision #/#/EC 49 See IRS Publication 49 DARWINS 49 § #.#-# [002] 49 #:#-# [010] 49 Listing Rule #.#.# [005] 49 RC #.# B [001] 49 Evid. Code § § 49 Diabetic Kidney Disease 49 GENERAL INFORMATION 49 symbols ISIN FR